These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37298191)

  • 1. MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression.
    Compagnoni C; Capelli R; Zelli V; Corrente A; Vecchiotti D; Flati I; Di Vito Nolfi M; Angelucci A; Alesse E; Zazzeroni F; Tessitore A
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
    Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
    BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-21-5p promotes NASH-related hepatocarcinogenesis.
    Rodrigues PM; Afonso MB; Simão AL; Islam T; Gaspar MM; O'Rourke CJ; Lewinska M; Andersen JB; Arretxe E; Alonso C; Santos-Laso Á; Izquierdo-Sanchez L; Jimenez-Agüero R; Eizaguirre E; Bujanda L; Pareja MJ; Prip-Buus C; Banales JM; Rodrigues CMP; Castro RE
    Liver Int; 2023 Oct; 43(10):2256-2274. PubMed ID: 37534739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p.
    Wang S; Xu M; Sun Z; Yu X; Deng Y; Chang H
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G116-G126. PubMed ID: 31021172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes.
    He Y; Hwang S; Cai Y; Kim SJ; Xu M; Yang D; Guillot A; Feng D; Seo W; Hou X; Gao B
    Hepatology; 2019 Oct; 70(4):1150-1167. PubMed ID: 30964207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma.
    Huang DH; Wang GY; Zhang JW; Li Y; Zeng XC; Jiang N
    Jpn J Clin Oncol; 2015 Aug; 45(8):738-44. PubMed ID: 25917358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1.
    Pu J; Wu X; Wu Y; Shao Z; Luo C; Tang Q; Wang J; Wei H; Lu Y
    Aging (Albany NY); 2021 Mar; 13(8):12207-12223. PubMed ID: 33952719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease.
    Fernández-Tussy P; Fernández-Ramos D; Lopitz-Otsoa F; Simón J; Barbier-Torres L; Gomez-Santos B; Nuñez-Garcia M; Azkargorta M; Gutiérrez-de Juan V; Serrano-Macia M; Rodríguez-Agudo R; Iruzubieta P; Anguita J; Castro RE; Champagne D; Rincón M; Elortza F; Arslanow A; Krawczyk M; Lammert F; Kirchmeyer M; Behrmann I; Crespo J; Lu SC; Mato JM; Varela-Rey M; Aspichueta P; Delgado TC; Martínez-Chantar ML
    Mol Metab; 2019 Nov; 29():40-54. PubMed ID: 31668391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma.
    Hu H; Huang W; Zhang H; Li J; Zhang Q; Miao YR; Hu FF; Gan L; Su Z; Yang X; Guo AY
    Cells; 2022 Jul; 11(13):. PubMed ID: 35805200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling.
    Kundu D; Kennedy L; Zhou T; Ekser B; Meadows V; Sybenga A; Kyritsi K; Chen L; Ceci L; Wu N; Wu C; Glaser S; Carpino G; Onori P; Gaudio E; Alpini G; Francis H
    Hepatology; 2023 Jul; 78(1):243-257. PubMed ID: 36799449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A micro-RNA expression signature for human NAFLD progression.
    Guo Y; Xiong Y; Sheng Q; Zhao S; Wattacheril J; Flynn CR
    J Gastroenterol; 2016 Oct; 51(10):1022-30. PubMed ID: 26874844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
    Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
    Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
    Hochreuter MY; Dall M; Treebak JT; Barrès R
    Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Verification of a Novel MAGI2-AS3/miRNA-374-5p/FOXO1 Network Associated with HBV-Related HCC.
    Wang C; Su K; Lin H; Cen B; Zheng S; Xu X
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
    Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
    Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-218-5p promotes hepatic lipogenesis through targeting Elovl5 in non-alcoholic fatty liver disease.
    Wu G; Zhang Y; Liang B; Yin L; Gao M; Zhang H; Xu Y; Han X; Qi Y; Liu F; Xu L
    Biochem Pharmacol; 2024 Aug; 226():116411. PubMed ID: 38972428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
    Tian F; Ying HM; Wang YY; Cheng BN; Chen J
    Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.
    Chen X; Ma H; Gao Y; Jin Y; Ning W; Hou Y; Su J
    Bioengineered; 2021 Dec; 12(1):6738-6747. PubMed ID: 34511037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
    Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
    Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.